PubMed:16867246
Annnotations
LitCoin-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-119 | Sentence | denotes | Association of DRD2 polymorphisms and chlorpromazine-induced extrapyramidal syndrome in Chinese schizophrenic patients. |
| T2 | 120-124 | Sentence | denotes | AIM: |
| T3 | 125-259 | Sentence | denotes | Extrapyramidal syndrome (EPS) is most commonly affected by typical antipsychotic drugs that have a high affinity with the D2 receptor. |
| T4 | 260-525 | Sentence | denotes | Recently, many research groups have reported on the positive relationship between the genetic variations in the DRD2 gene and the therapeutic response in schizophrenia patients as a result of the role of variations in the receptor in modulating receptor expression. |
| T5 | 526-629 | Sentence | denotes | In this study, we evaluate the role DRD2 plays in chlorpromazine-induced EPS in schizophrenic patients. |
| T6 | 630-638 | Sentence | denotes | METHODS: |
| T7 | 639-922 | Sentence | denotes | We identified seven SNP(single nucleotide polymorphism) (-141Cins>del, TaqIB, TaqID, Ser311Cys, rs6275, rs6277 and TaqIA) in the DRD2 gene in 146 schizophrenic inpatients (59 with EPS and 87 without EPS according to the Simpson-Angus Scale) treated with chlorpromazine after 8 weeks. |
| T8 | 923-998 | Sentence | denotes | The alleles of all loci were determined by PCR (polymerase chain reaction). |
| T9 | 999-1007 | Sentence | denotes | RESULTS: |
| T10 | 1008-1120 | Sentence | denotes | Polymorphisms TaqID, Ser311Cys and rs6277 were not polymorphic in the population recruited in the present study. |
| T11 | 1121-1348 | Sentence | denotes | No statistical significance was found in the allele distribution of -141Cins>del, TaqIB, rs6275 and TaqIA or in the estimated haplotypes (constituted by TaqIB, rs6275 and TaqIA) in linkage disequilibrium between the two groups. |
| T12 | 1349-1360 | Sentence | denotes | CONCLUSION: |
| T13 | 1361-1595 | Sentence | denotes | Our results did not lend strong support to the view that the genetic variation of the DRD2 gene plays a major role in the individually variable adverse effect induced by chlorpromazine, at least in Chinese patients with schizophrenia. |
| T14 | 1596-1690 | Sentence | denotes | Our results confirmed a previous study on the relationship between DRD2 and EPS in Caucasians. |
LitCoin-entities
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| 3315 | 15-19 | GeneOrGeneProduct | denotes | DRD2 | NCBIGene:1813 |
| 3316 | 38-52 | ChemicalEntity | denotes | chlorpromazine | MESH:D002746 |
| 3317 | 61-84 | DiseaseOrPhenotypicFeature | denotes | extrapyramidal syndrome | MESH:D001480 |
| 3318 | 96-109 | DiseaseOrPhenotypicFeature | denotes | schizophrenic | MESH:D012559 |
| 3319 | 110-118 | OrganismTaxon | denotes | patients | NCBITaxon:9606 |
| 3320 | 125-148 | DiseaseOrPhenotypicFeature | denotes | Extrapyramidal syndrome | MESH:D001480 |
| 3321 | 150-153 | DiseaseOrPhenotypicFeature | denotes | EPS | MESH:D001480 |
| 3322 | 192-211 | ChemicalEntity | denotes | antipsychotic drugs | MESH:D014150 |
| 3323 | 247-258 | GeneOrGeneProduct | denotes | D2 receptor | NCBIGene:1813 |
| 3324 | 372-376 | GeneOrGeneProduct | denotes | DRD2 | NCBIGene:1813 |
| 3325 | 414-427 | DiseaseOrPhenotypicFeature | denotes | schizophrenia | MESH:D012559 |
| 3326 | 428-436 | OrganismTaxon | denotes | patients | NCBITaxon:9606 |
| 3327 | 562-566 | GeneOrGeneProduct | denotes | DRD2 | NCBIGene:1813 |
| 3328 | 576-590 | ChemicalEntity | denotes | chlorpromazine | MESH:D002746 |
| 3329 | 599-602 | DiseaseOrPhenotypicFeature | denotes | EPS | MESH:D001480 |
| 3330 | 606-619 | DiseaseOrPhenotypicFeature | denotes | schizophrenic | MESH:D012559 |
| 3331 | 620-628 | OrganismTaxon | denotes | patients | NCBITaxon:9606 |
| 3332 | 696-708 | SequenceVariant | denotes | -141Cins>del | c|INDEL|0141|C |
| 3333 | 724-733 | SequenceVariant | denotes | Ser311Cys | c|SUB|S|311|C |
| 3334 | 735-741 | SequenceVariant | denotes | rs6275 | DBSNP:rs6275 |
| 3335 | 743-749 | SequenceVariant | denotes | rs6277 | DBSNP:rs6277 |
| 3336 | 768-772 | GeneOrGeneProduct | denotes | DRD2 | NCBIGene:1813 |
| 3337 | 785-798 | DiseaseOrPhenotypicFeature | denotes | schizophrenic | MESH:D012559 |
| 3338 | 799-809 | OrganismTaxon | denotes | inpatients | NCBITaxon:9606 |
| 3339 | 819-822 | DiseaseOrPhenotypicFeature | denotes | EPS | MESH:D001480 |
| 3340 | 838-841 | DiseaseOrPhenotypicFeature | denotes | EPS | MESH:D001480 |
| 3341 | 893-907 | ChemicalEntity | denotes | chlorpromazine | MESH:D002746 |
| 3342 | 1029-1038 | SequenceVariant | denotes | Ser311Cys | c|SUB|S|311|C |
| 3343 | 1043-1049 | SequenceVariant | denotes | rs6277 | DBSNP:rs6277 |
| 3344 | 1189-1201 | SequenceVariant | denotes | -141Cins>del | c|INDEL|0141|C |
| 3345 | 1210-1216 | SequenceVariant | denotes | rs6275 | DBSNP:rs6275 |
| 3346 | 1281-1287 | SequenceVariant | denotes | rs6275 | DBSNP:rs6275 |
| 3347 | 1447-1451 | GeneOrGeneProduct | denotes | DRD2 | NCBIGene:1813 |
| 3348 | 1531-1545 | ChemicalEntity | denotes | chlorpromazine | MESH:D002746 |
| 3349 | 1567-1575 | OrganismTaxon | denotes | patients | NCBITaxon:9606 |
| 3350 | 1581-1594 | DiseaseOrPhenotypicFeature | denotes | schizophrenia | MESH:D012559 |
| 3351 | 1663-1667 | GeneOrGeneProduct | denotes | DRD2 | NCBIGene:1813 |
| 3352 | 1672-1675 | DiseaseOrPhenotypicFeature | denotes | EPS | MESH:D001480 |
LitCoin_Mondo
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 414-427 | DiseaseOrPhenotypicFeature | denotes | schizophrenia | 0005090 |
| T2 | 1581-1594 | DiseaseOrPhenotypicFeature | denotes | schizophrenia | 0005090 |
LitCoin-SeqVar
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 724-733 | SequenceVariant | denotes | Ser311Cys |
| T2 | 735-741 | SequenceVariant | denotes | rs6275 |
| T3 | 743-749 | SequenceVariant | denotes | rs6277 |
| T4 | 1029-1038 | SequenceVariant | denotes | Ser311Cys |
| T5 | 1043-1049 | SequenceVariant | denotes | rs6277 |
| T6 | 1210-1216 | SequenceVariant | denotes | rs6275 |
| T7 | 1281-1287 | SequenceVariant | denotes | rs6275 |
LitCoin-GeneOrGeneProduct-v0
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 15-19 | GeneOrGeneProduct | denotes | DRD2 |
| T2 | 53-60 | GeneOrGeneProduct | denotes | induced |
| T3 | 76-84 | GeneOrGeneProduct | denotes | syndrome |
| T4 | 140-148 | GeneOrGeneProduct | denotes | syndrome |
| T5 | 224-228 | GeneOrGeneProduct | denotes | high |
| T6 | 250-258 | GeneOrGeneProduct | denotes | receptor |
| T7 | 270-274 | GeneOrGeneProduct | denotes | many |
| T8 | 372-376 | GeneOrGeneProduct | denotes | DRD2 |
| T9 | 482-490 | GeneOrGeneProduct | denotes | receptor |
| T10 | 505-513 | GeneOrGeneProduct | denotes | receptor |
| T11 | 562-566 | GeneOrGeneProduct | denotes | DRD2 |
| T12 | 591-598 | GeneOrGeneProduct | denotes | induced |
| T13 | 630-637 | GeneOrGeneProduct | denotes | METHODS |
| T14 | 705-708 | GeneOrGeneProduct | denotes | del |
| T15 | 768-772 | GeneOrGeneProduct | denotes | DRD2 |
| T16 | 938-941 | GeneOrGeneProduct | denotes | all |
| T17 | 952-962 | GeneOrGeneProduct | denotes | determined |
| T18 | 971-981 | GeneOrGeneProduct | denotes | polymerase |
| T19 | 982-987 | GeneOrGeneProduct | denotes | chain |
| T20 | 1198-1201 | GeneOrGeneProduct | denotes | del |
| T21 | 1447-1451 | GeneOrGeneProduct | denotes | DRD2 |
| T22 | 1465-1470 | GeneOrGeneProduct | denotes | major |
| T23 | 1520-1527 | GeneOrGeneProduct | denotes | induced |
| T24 | 1663-1667 | GeneOrGeneProduct | denotes | DRD2 |
LitCoin-GeneOrGeneProduct-v2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 15-19 | GeneOrGeneProduct | denotes | DRD2 |
| T2 | 76-84 | GeneOrGeneProduct | denotes | syndrome |
| T3 | 140-148 | GeneOrGeneProduct | denotes | syndrome |
| T4 | 224-228 | GeneOrGeneProduct | denotes | high |
| T5 | 250-258 | GeneOrGeneProduct | denotes | receptor |
| T6 | 372-376 | GeneOrGeneProduct | denotes | DRD2 |
| T7 | 482-490 | GeneOrGeneProduct | denotes | receptor |
| T8 | 505-513 | GeneOrGeneProduct | denotes | receptor |
| T9 | 562-566 | GeneOrGeneProduct | denotes | DRD2 |
| T10 | 768-772 | GeneOrGeneProduct | denotes | DRD2 |
| T11 | 971-981 | GeneOrGeneProduct | denotes | polymerase |
| T12 | 982-987 | GeneOrGeneProduct | denotes | chain |
| T13 | 1447-1451 | GeneOrGeneProduct | denotes | DRD2 |
| T14 | 1465-1470 | GeneOrGeneProduct | denotes | major |
| T15 | 1663-1667 | GeneOrGeneProduct | denotes | DRD2 |
LitCoin-Disease-MeSH
| Id | Subject | Object | Predicate | Lexical cue | originalLabel |
|---|---|---|---|---|---|
| T1 | 76-84 | DiseaseOrPhenotypicFeature | denotes | syndrome | D013577 |
| T2 | 96-109 | DiseaseOrPhenotypicFeature | denotes | schizophrenic | DISEASE |
| T3 | 140-148 | DiseaseOrPhenotypicFeature | denotes | syndrome | D013577 |
| T4 | 414-427 | DiseaseOrPhenotypicFeature | denotes | schizophrenia | D012559 |
| T5 | 606-619 | DiseaseOrPhenotypicFeature | denotes | schizophrenic | DISEASE |
| T6 | 785-798 | DiseaseOrPhenotypicFeature | denotes | schizophrenic | DISEASE |
| T7 | 1581-1594 | DiseaseOrPhenotypicFeature | denotes | schizophrenia | D012559 |
LitCoin_Mondo_095
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 76-84 | DiseaseOrPhenotypicFeature | denotes | syndrome | 0002254 |
| T2 | 140-148 | DiseaseOrPhenotypicFeature | denotes | syndrome | 0002254 |
| T3 | 414-427 | DiseaseOrPhenotypicFeature | denotes | schizophrenia | 0005090 |
| T4 | 1581-1594 | DiseaseOrPhenotypicFeature | denotes | schizophrenia | 0005090 |
LitCoin-GeneOrGeneProduct-v3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 15-19 | GeneOrGeneProduct | denotes | DRD2 |
| T2 | 247-258 | GeneOrGeneProduct | denotes | D2 receptor |
| T3 | 372-376 | GeneOrGeneProduct | denotes | DRD2 |
| T4 | 562-566 | GeneOrGeneProduct | denotes | DRD2 |
| T5 | 768-772 | GeneOrGeneProduct | denotes | DRD2 |
| T6 | 1447-1451 | GeneOrGeneProduct | denotes | DRD2 |
| T7 | 1663-1667 | GeneOrGeneProduct | denotes | DRD2 |
LitCoin-MeSH-Disease-2
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T1 | 76-84 | DiseaseOrPhenotypicFeature | denotes | syndrome | D013577 |
| T2 | 96-109 | DiseaseOrPhenotypicFeature | denotes | schizophrenic | DISEASE |
| T3 | 140-148 | DiseaseOrPhenotypicFeature | denotes | syndrome | D013577 |
| T4 | 150-153 | DiseaseOrPhenotypicFeature | denotes | EPS | DISEASE |
| T5 | 414-427 | DiseaseOrPhenotypicFeature | denotes | schizophrenia | D012559 |
| T6 | 599-602 | DiseaseOrPhenotypicFeature | denotes | EPS | DISEASE |
| T7 | 606-619 | DiseaseOrPhenotypicFeature | denotes | schizophrenic | DISEASE |
| T8 | 785-798 | DiseaseOrPhenotypicFeature | denotes | schizophrenic | DISEASE |
| T9 | 819-822 | DiseaseOrPhenotypicFeature | denotes | EPS | DISEASE |
| T10 | 838-841 | DiseaseOrPhenotypicFeature | denotes | EPS | DISEASE |
| T11 | 1581-1594 | DiseaseOrPhenotypicFeature | denotes | schizophrenia | D012559 |
| T12 | 1672-1675 | DiseaseOrPhenotypicFeature | denotes | EPS | DISEASE |
LitCoin-MONDO_bioort2019
| Id | Subject | Object | Predicate | Lexical cue | #label |
|---|---|---|---|---|---|
| T1 | 61-84 | DiseaseOrPhenotypicFeature | denotes | extrapyramidal syndrome | EisukeAdded |
| T2 | 96-109 | DiseaseOrPhenotypicFeature | denotes | schizophrenic | DISEASE |
| T3 | 125-148 | DiseaseOrPhenotypicFeature | denotes | Extrapyramidal syndrome | EisukeAdded |
| T4 | 150-153 | DiseaseOrPhenotypicFeature | denotes | EPS | DISEASE|EisukeAdded |
| T6 | 414-427 | DiseaseOrPhenotypicFeature | denotes | schizophrenia | D012559 |
| T7 | 599-602 | DiseaseOrPhenotypicFeature | denotes | EPS | DISEASE|EisukeAdded |
| T9 | 606-619 | DiseaseOrPhenotypicFeature | denotes | schizophrenic | DISEASE |
| T10 | 785-798 | DiseaseOrPhenotypicFeature | denotes | schizophrenic | DISEASE |
| T11 | 819-822 | DiseaseOrPhenotypicFeature | denotes | EPS | DISEASE|EisukeAdded |
| T13 | 838-841 | DiseaseOrPhenotypicFeature | denotes | EPS | DISEASE|EisukeAdded |
| T15 | 1581-1594 | DiseaseOrPhenotypicFeature | denotes | schizophrenia | D012559 |
| T16 | 1672-1675 | DiseaseOrPhenotypicFeature | denotes | EPS | DISEASE|EisukeAdded |
LitCoin-NCBITaxon-2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 110-118 | OrganismTaxon | denotes | patients |
| T2 | 428-436 | OrganismTaxon | denotes | patients |
| T3 | 620-628 | OrganismTaxon | denotes | patients |
| T4 | 1567-1575 | OrganismTaxon | denotes | patients |
LitCoin-Chemical-MeSH-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T1 | 38-52 | ChemicalEntity | denotes | chlorpromazine | D002746|http://purl.obolibrary.org/obo/CHEBI_3647 |
| T3 | 120-123 | ChemicalEntity | denotes | AIM | http://purl.obolibrary.org/obo/CHEBI_3416 |
| T4 | 576-590 | ChemicalEntity | denotes | chlorpromazine | D002746|http://purl.obolibrary.org/obo/CHEBI_3647 |
| T6 | 893-907 | ChemicalEntity | denotes | chlorpromazine | D002746|http://purl.obolibrary.org/obo/CHEBI_3647 |
| T8 | 1531-1545 | ChemicalEntity | denotes | chlorpromazine | D002746|http://purl.obolibrary.org/obo/CHEBI_3647 |
LitCoin-training-merged
| Id | Subject | Object | Predicate | Lexical cue | #label | ID: |
|---|---|---|---|---|---|---|
| T8 | 1531-1545 | ChemicalEntity | denotes | chlorpromazine | http://purl.obolibrary.org/obo/CHEBI_3647|D002746 | |
| T6 | 893-907 | ChemicalEntity | denotes | chlorpromazine | http://purl.obolibrary.org/obo/CHEBI_3647|D002746 | |
| T4 | 576-590 | ChemicalEntity | denotes | chlorpromazine | http://purl.obolibrary.org/obo/CHEBI_3647|D002746 | |
| T3 | 120-123 | ChemicalEntity | denotes | AIM | http://purl.obolibrary.org/obo/CHEBI_3416 | |
| T1 | 38-52 | ChemicalEntity | denotes | chlorpromazine | http://purl.obolibrary.org/obo/CHEBI_3647|D002746 | |
| T7 | 1663-1667 | GeneOrGeneProduct | denotes | DRD2 | ||
| T96406 | 1447-1451 | GeneOrGeneProduct | denotes | DRD2 | ||
| T5 | 768-772 | GeneOrGeneProduct | denotes | DRD2 | ||
| T20069 | 562-566 | GeneOrGeneProduct | denotes | DRD2 | ||
| T14311 | 372-376 | GeneOrGeneProduct | denotes | DRD2 | ||
| T2 | 247-258 | GeneOrGeneProduct | denotes | D2 receptor | ||
| T91332 | 15-19 | GeneOrGeneProduct | denotes | DRD2 | ||
| T16 | 1672-1675 | DiseaseOrPhenotypicFeature | denotes | EPS | EisukeAdded|DISEASE | |
| T15 | 1581-1594 | DiseaseOrPhenotypicFeature | denotes | schizophrenia | D012559 | |
| T13 | 838-841 | DiseaseOrPhenotypicFeature | denotes | EPS | EisukeAdded|DISEASE | |
| T11 | 819-822 | DiseaseOrPhenotypicFeature | denotes | EPS | EisukeAdded|DISEASE | |
| T10 | 785-798 | DiseaseOrPhenotypicFeature | denotes | schizophrenic | DISEASE | |
| T9 | 606-619 | DiseaseOrPhenotypicFeature | denotes | schizophrenic | DISEASE | |
| T85049 | 599-602 | DiseaseOrPhenotypicFeature | denotes | EPS | EisukeAdded|DISEASE | |
| T71831 | 414-427 | DiseaseOrPhenotypicFeature | denotes | schizophrenia | D012559 | |
| T22579 | 150-153 | DiseaseOrPhenotypicFeature | denotes | EPS | EisukeAdded|DISEASE | |
| T80435 | 125-148 | DiseaseOrPhenotypicFeature | denotes | Extrapyramidal syndrome | EisukeAdded | |
| T8275 | 96-109 | DiseaseOrPhenotypicFeature | denotes | schizophrenic | DISEASE | |
| T13478 | 61-84 | DiseaseOrPhenotypicFeature | denotes | extrapyramidal syndrome | EisukeAdded | |
| T69768 | 1567-1575 | OrganismTaxon | denotes | patients | ||
| T21342 | 620-628 | OrganismTaxon | denotes | patients | ||
| T23833 | 428-436 | OrganismTaxon | denotes | patients | ||
| T4401 | 110-118 | OrganismTaxon | denotes | patients | ||
| T51684 | 1281-1287 | SequenceVariant | denotes | rs6275 | ||
| T13030 | 1210-1216 | SequenceVariant | denotes | rs6275 | ||
| T54176 | 1043-1049 | SequenceVariant | denotes | rs6277 | ||
| T12677 | 1029-1038 | SequenceVariant | denotes | Ser311Cys | ||
| T11303 | 743-749 | SequenceVariant | denotes | rs6277 | ||
| T38827 | 735-741 | SequenceVariant | denotes | rs6275 | ||
| T44931 | 724-733 | SequenceVariant | denotes | Ser311Cys |
DisGeNET5_variant_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 16867246-4#104#110#geners6277 | 743-749 | geners6277 | denotes | rs6277 |
| 16867246-4#180#183#diseaseC0221271 | 819-822 | diseaseC0221271 | denotes | EPS |
| 16867246-4#180#183#diseaseC1868684 | 819-822 | diseaseC1868684 | denotes | EPS |
| 16867246-4#199#202#diseaseC0221271 | 838-841 | diseaseC0221271 | denotes | EPS |
| 16867246-4#199#202#diseaseC1868684 | 838-841 | diseaseC1868684 | denotes | EPS |
| 104#110#geners6277180#183#diseaseC0221271 | 16867246-4#104#110#geners6277 | 16867246-4#180#183#diseaseC0221271 | associated_with | rs6277,EPS |
| 104#110#geners6277180#183#diseaseC1868684 | 16867246-4#104#110#geners6277 | 16867246-4#180#183#diseaseC1868684 | associated_with | rs6277,EPS |
| 104#110#geners6277199#202#diseaseC0221271 | 16867246-4#104#110#geners6277 | 16867246-4#199#202#diseaseC0221271 | associated_with | rs6277,EPS |
| 104#110#geners6277199#202#diseaseC1868684 | 16867246-4#104#110#geners6277 | 16867246-4#199#202#diseaseC1868684 | associated_with | rs6277,EPS |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 16867246-0#15#19#gene1813 | 15-19 | gene1813 | denotes | DRD2 |
| 16867246-0#61#84#diseaseC0015371 | 61-84 | diseaseC0015371 | denotes | extrapyramidal syndrome |
| 16867246-8#86#90#gene1813 | 1447-1451 | gene1813 | denotes | DRD2 |
| 16867246-8#220#233#diseaseC0036341 | 1581-1594 | diseaseC0036341 | denotes | schizophrenia |
| 16867246-9#67#71#gene1813 | 1663-1667 | gene1813 | denotes | DRD2 |
| 16867246-9#76#79#diseaseC0221271 | 1672-1675 | diseaseC0221271 | denotes | EPS |
| 16867246-9#76#79#diseaseC1868684 | 1672-1675 | diseaseC1868684 | denotes | EPS |
| 15#19#gene181361#84#diseaseC0015371 | 16867246-0#15#19#gene1813 | 16867246-0#61#84#diseaseC0015371 | associated_with | DRD2,extrapyramidal syndrome |
| 86#90#gene1813220#233#diseaseC0036341 | 16867246-8#86#90#gene1813 | 16867246-8#220#233#diseaseC0036341 | associated_with | DRD2,schizophrenia |
| 67#71#gene181376#79#diseaseC0221271 | 16867246-9#67#71#gene1813 | 16867246-9#76#79#diseaseC0221271 | associated_with | DRD2,EPS |
| 67#71#gene181376#79#diseaseC1868684 | 16867246-9#67#71#gene1813 | 16867246-9#76#79#diseaseC1868684 | associated_with | DRD2,EPS |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 15-19 | gene:1813 | denotes | DRD2 |
| T1 | 61-84 | disease:C0015371 | denotes | extrapyramidal syndrome |
| T2 | 562-566 | gene:1813 | denotes | DRD2 |
| T3 | 599-602 | disease:C0015371 | denotes | EPS |
| T4 | 768-772 | gene:1813 | denotes | DRD2 |
| T5 | 819-822 | disease:C0015371 | denotes | EPS |
| T6 | 768-772 | gene:1813 | denotes | DRD2 |
| T7 | 838-841 | disease:C0015371 | denotes | EPS |
| T8 | 1447-1451 | gene:1813 | denotes | DRD2 |
| T9 | 1581-1594 | disease:C0036341 | denotes | schizophrenia |
| T10 | 1663-1667 | gene:1813 | denotes | DRD2 |
| T11 | 1672-1675 | disease:C0015371 | denotes | EPS |
| R1 | T0 | T1 | associated_with | DRD2,extrapyramidal syndrome |
| R2 | T2 | T3 | associated_with | DRD2,EPS |
| R3 | T4 | T5 | associated_with | DRD2,EPS |
| R4 | T6 | T7 | associated_with | DRD2,EPS |
| R5 | T8 | T9 | associated_with | DRD2,schizophrenia |
| R6 | T10 | T11 | associated_with | DRD2,EPS |
biored-valid-deepseek-nr-ng
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 15-19 | GeneOrGeneProduct | denotes | DRD2 |
| T2 | 38-60 | ChemicalEntity | denotes | chlorpromazine-induced |
| T3 | 61-84 | DiseaseOrPhenotypicFeature | denotes | extrapyramidal syndrome |
| T4 | 88-109 | DiseaseOrPhenotypicFeature | denotes | Chinese schizophrenic |
| T5 | 125-148 | DiseaseOrPhenotypicFeature | denotes | Extrapyramidal syndrome |
| T6 | 150-153 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T7 | 247-249 | GeneOrGeneProduct | denotes | D2 |
| T8 | 372-376 | GeneOrGeneProduct | denotes | DRD2 |
| T9 | 562-566 | GeneOrGeneProduct | denotes | DRD2 |
| T10 | 576-598 | ChemicalEntity | denotes | chlorpromazine-induced |
| T11 | 599-602 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T12 | 606-628 | DiseaseOrPhenotypicFeature | denotes | schizophrenic patients |
| T13 | 659-662 | SequenceVariant | denotes | SNP |
| T14 | 696-708 | SequenceVariant | denotes | -141Cins>del |
| T15 | 710-715 | SequenceVariant | denotes | TaqIB |
| T16 | 717-722 | SequenceVariant | denotes | TaqID |
| T17 | 724-733 | SequenceVariant | denotes | Ser311Cys |
| T18 | 735-741 | SequenceVariant | denotes | rs6275 |
| T19 | 743-749 | SequenceVariant | denotes | rs6277 |
| T20 | 754-759 | SequenceVariant | denotes | TaqIA |
| T21 | 785-809 | DiseaseOrPhenotypicFeature | denotes | schizophrenic inpatients |
| T22 | 859-878 | DiseaseOrPhenotypicFeature | denotes | Simpson-Angus Scale |
| T23 | 893-907 | ChemicalEntity | denotes | chlorpromazine |
| T24 | 966-969 | ChemicalEntity | denotes | PCR |
| T25 | 971-996 | ChemicalEntity | denotes | polymerase chain reaction |
| T26 | 1189-1201 | SequenceVariant | denotes | -141Cins>del |
| T27 | 1203-1208 | SequenceVariant | denotes | TaqIB |
| T28 | 1210-1216 | SequenceVariant | denotes | rs6275 |
| T29 | 1221-1226 | SequenceVariant | denotes | TaqIA |
| T30 | 1447-1451 | GeneOrGeneProduct | denotes | DRD2 |
| T31 | 1559-1575 | OrganismTaxon | denotes | Chinese patients |
| T32 | 1581-1594 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
| T33 | 1672-1675 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T34 | 1679-1689 | OrganismTaxon | denotes | Caucasians |
biored-valid
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 15-19 | GeneOrGeneProduct | denotes | DRD2 |
| T2 | 38-52 | ChemicalEntity | denotes | chlorpromazine |
| T3 | 61-84 | DiseaseOrPhenotypicFeature | denotes | extrapyramidal syndrome |
| T4 | 96-109 | DiseaseOrPhenotypicFeature | denotes | schizophrenic |
| T5 | 110-118 | OrganismTaxon | denotes | patients |
| T6 | 125-148 | DiseaseOrPhenotypicFeature | denotes | Extrapyramidal syndrome |
| T7 | 150-153 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T8 | 192-211 | ChemicalEntity | denotes | antipsychotic drugs |
| T9 | 247-258 | GeneOrGeneProduct | denotes | D2 receptor |
| T10 | 372-376 | GeneOrGeneProduct | denotes | DRD2 |
| T11 | 414-427 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
| T12 | 428-436 | OrganismTaxon | denotes | patients |
| T13 | 562-566 | GeneOrGeneProduct | denotes | DRD2 |
| T14 | 576-590 | ChemicalEntity | denotes | chlorpromazine |
| T15 | 599-602 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T16 | 606-619 | DiseaseOrPhenotypicFeature | denotes | schizophrenic |
| T17 | 620-628 | OrganismTaxon | denotes | patients |
| T18 | 696-708 | SequenceVariant | denotes | -141Cins>del |
| T19 | 724-733 | SequenceVariant | denotes | Ser311Cys |
| T20 | 735-741 | SequenceVariant | denotes | rs6275 |
| T21 | 743-749 | SequenceVariant | denotes | rs6277 |
| T22 | 768-772 | GeneOrGeneProduct | denotes | DRD2 |
| T23 | 785-798 | DiseaseOrPhenotypicFeature | denotes | schizophrenic |
| T24 | 799-809 | OrganismTaxon | denotes | inpatients |
| T25 | 819-822 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T26 | 838-841 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T27 | 893-907 | ChemicalEntity | denotes | chlorpromazine |
| T28 | 1029-1038 | SequenceVariant | denotes | Ser311Cys |
| T29 | 1043-1049 | SequenceVariant | denotes | rs6277 |
| T30 | 1189-1201 | SequenceVariant | denotes | -141Cins>del |
| T31 | 1210-1216 | SequenceVariant | denotes | rs6275 |
| T32 | 1281-1287 | SequenceVariant | denotes | rs6275 |
| T33 | 1447-1451 | GeneOrGeneProduct | denotes | DRD2 |
| T34 | 1531-1545 | ChemicalEntity | denotes | chlorpromazine |
| T35 | 1567-1575 | OrganismTaxon | denotes | patients |
| T36 | 1581-1594 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
| T37 | 1663-1667 | GeneOrGeneProduct | denotes | DRD2 |
| T38 | 1672-1675 | DiseaseOrPhenotypicFeature | denotes | EPS |
biored-valid-deepseek-nr-g
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 15-19 | GeneOrGeneProduct | denotes | DRD2 |
| T2 | 38-52 | ChemicalEntity | denotes | chlorpromazine |
| T3 | 61-84 | DiseaseOrPhenotypicFeature | denotes | extrapyramidal syndrome |
| T4 | 88-109 | DiseaseOrPhenotypicFeature | denotes | Chinese schizophrenic |
| T5 | 125-148 | DiseaseOrPhenotypicFeature | denotes | Extrapyramidal syndrome |
| T6 | 150-153 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T7 | 247-249 | GeneOrGeneProduct | denotes | D2 |
| T8 | 372-376 | GeneOrGeneProduct | denotes | DRD2 |
| T9 | 414-427 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
| T10 | 562-566 | GeneOrGeneProduct | denotes | DRD2 |
| T11 | 576-590 | ChemicalEntity | denotes | chlorpromazine |
| T12 | 599-602 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T13 | 606-628 | DiseaseOrPhenotypicFeature | denotes | schizophrenic patients |
| T14 | 659-662 | SequenceVariant | denotes | SNP |
| T15 | 681-693 | SequenceVariant | denotes | polymorphism |
| T16 | 696-708 | SequenceVariant | denotes | -141Cins>del |
| T17 | 710-715 | SequenceVariant | denotes | TaqIB |
| T18 | 717-722 | SequenceVariant | denotes | TaqID |
| T19 | 724-733 | SequenceVariant | denotes | Ser311Cys |
| T20 | 735-741 | SequenceVariant | denotes | rs6275 |
| T21 | 743-749 | SequenceVariant | denotes | rs6277 |
| T22 | 754-759 | SequenceVariant | denotes | TaqIA |
| T23 | 768-772 | GeneOrGeneProduct | denotes | DRD2 |
| T24 | 785-809 | DiseaseOrPhenotypicFeature | denotes | schizophrenic inpatients |
| T25 | 819-822 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T26 | 838-841 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T27 | 859-878 | DiseaseOrPhenotypicFeature | denotes | Simpson-Angus Scale |
| T28 | 893-907 | ChemicalEntity | denotes | chlorpromazine |
| T29 | 1203-1208 | SequenceVariant | denotes | TaqIB |
| T30 | 1447-1451 | GeneOrGeneProduct | denotes | DRD2 |
| T31 | 1581-1594 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
| T32 | 1679-1689 | OrganismTaxon | denotes | Caucasians |
biored-valid-deepseek-r-ng
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 15-19 | GeneOrGeneProduct | denotes | DRD2 |
| T2 | 38-52 | ChemicalEntity | denotes | chlorpromazine |
| T3 | 61-84 | DiseaseOrPhenotypicFeature | denotes | extrapyramidal syndrome |
| T4 | 96-109 | DiseaseOrPhenotypicFeature | denotes | schizophrenic |
| T5 | 150-153 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T6 | 247-258 | GeneOrGeneProduct | denotes | D2 receptor |
| T7 | 372-381 | GeneOrGeneProduct | denotes | DRD2 gene |
| T8 | 414-427 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
| T9 | 576-590 | ChemicalEntity | denotes | chlorpromazine |
| T10 | 599-602 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T11 | 696-708 | SequenceVariant | denotes | -141Cins>del |
| T12 | 710-715 | SequenceVariant | denotes | TaqIB |
| T13 | 717-722 | SequenceVariant | denotes | TaqID |
| T14 | 724-733 | SequenceVariant | denotes | Ser311Cys |
| T15 | 735-741 | SequenceVariant | denotes | rs6275 |
| T16 | 743-749 | SequenceVariant | denotes | rs6277 |
| T17 | 754-759 | SequenceVariant | denotes | TaqIA |
| T18 | 768-772 | GeneOrGeneProduct | denotes | DRD2 |
| T19 | 838-841 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T20 | 893-907 | ChemicalEntity | denotes | chlorpromazine |
biored-valid-deepseek-r-g
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 15-19 | GeneOrGeneProduct | denotes | DRD2 |
| T2 | 38-52 | ChemicalEntity | denotes | chlorpromazine |
| T3 | 61-84 | DiseaseOrPhenotypicFeature | denotes | extrapyramidal syndrome |
| T4 | 96-109 | DiseaseOrPhenotypicFeature | denotes | schizophrenic |
| T5 | 125-148 | DiseaseOrPhenotypicFeature | denotes | Extrapyramidal syndrome |
| T6 | 150-153 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T7 | 247-258 | GeneOrGeneProduct | denotes | D2 receptor |
| T8 | 372-376 | GeneOrGeneProduct | denotes | DRD2 |
| T9 | 414-427 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
| T10 | 562-566 | GeneOrGeneProduct | denotes | DRD2 |
| T11 | 576-590 | ChemicalEntity | denotes | chlorpromazine |
| T12 | 599-602 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T13 | 606-619 | DiseaseOrPhenotypicFeature | denotes | schizophrenic |
| T14 | 659-662 | SequenceVariant | denotes | SNP |
| T15 | 663-693 | SequenceVariant | denotes | single nucleotide polymorphism |
| T16 | 696-708 | SequenceVariant | denotes | -141Cins>del |
| T17 | 710-715 | SequenceVariant | denotes | TaqIB |
| T18 | 717-722 | SequenceVariant | denotes | TaqID |
| T19 | 724-733 | SequenceVariant | denotes | Ser311Cys |
| T20 | 735-741 | SequenceVariant | denotes | rs6275 |
| T21 | 743-749 | SequenceVariant | denotes | rs6277 |
| T22 | 754-759 | SequenceVariant | denotes | TaqIA |
| T23 | 768-772 | GeneOrGeneProduct | denotes | DRD2 |
| T24 | 838-841 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T25 | 893-907 | ChemicalEntity | denotes | chlorpromazine |
biored-valid-gemini-nr-ng
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 15-19 | GeneOrGeneProduct | denotes | DRD2 |
| T2 | 38-52 | ChemicalEntity | denotes | chlorpromazine |
| T3 | 61-84 | DiseaseOrPhenotypicFeature | denotes | extrapyramidal syndrome |
| T4 | 88-109 | DiseaseOrPhenotypicFeature | denotes | Chinese schizophrenic |
| T5 | 125-148 | DiseaseOrPhenotypicFeature | denotes | Extrapyramidal syndrome |
| T6 | 150-153 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T7 | 247-258 | GeneOrGeneProduct | denotes | D2 receptor |
| T8 | 346-350 | GeneOrGeneProduct | denotes | gene |
| T9 | 372-376 | GeneOrGeneProduct | denotes | DRD2 |
| T10 | 414-427 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
| T11 | 562-566 | GeneOrGeneProduct | denotes | DRD2 |
| T12 | 576-590 | ChemicalEntity | denotes | chlorpromazine |
| T13 | 599-602 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T14 | 606-619 | DiseaseOrPhenotypicFeature | denotes | schizophrenic |
| T15 | 696-708 | SequenceVariant | denotes | -141Cins>del |
| T16 | 710-715 | SequenceVariant | denotes | TaqIB |
| T17 | 717-722 | SequenceVariant | denotes | TaqID |
| T18 | 724-733 | SequenceVariant | denotes | Ser311Cys |
| T19 | 735-741 | SequenceVariant | denotes | rs6275 |
| T20 | 743-749 | SequenceVariant | denotes | rs6277 |
| T21 | 754-759 | SequenceVariant | denotes | TaqIA |
| T22 | 773-777 | GeneOrGeneProduct | denotes | gene |
| T23 | 893-907 | ChemicalEntity | denotes | chlorpromazine |
| T24 | 1203-1208 | SequenceVariant | denotes | TaqIB |
| T25 | 1210-1216 | SequenceVariant | denotes | rs6275 |
| T26 | 1221-1226 | SequenceVariant | denotes | TaqIA |
| T27 | 1422-1426 | GeneOrGeneProduct | denotes | gene |
| T28 | 1447-1451 | GeneOrGeneProduct | denotes | DRD2 |
| T29 | 1559-1566 | OrganismTaxon | denotes | Chinese |
| T30 | 1581-1594 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
| T31 | 1672-1675 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T32 | 1679-1689 | OrganismTaxon | denotes | Caucasians |
biored-valid-gemini-r-ng
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 15-19 | GeneOrGeneProduct | denotes | DRD2 |
| T2 | 38-52 | ChemicalEntity | denotes | chlorpromazine |
| T3 | 61-84 | DiseaseOrPhenotypicFeature | denotes | extrapyramidal syndrome |
| T4 | 88-95 | OrganismTaxon | denotes | Chinese |
| T5 | 96-118 | DiseaseOrPhenotypicFeature | denotes | schizophrenic patients |
| T6 | 125-154 | DiseaseOrPhenotypicFeature | denotes | Extrapyramidal syndrome (EPS) |
| T7 | 192-211 | ChemicalEntity | denotes | antipsychotic drugs |
| T8 | 247-258 | GeneOrGeneProduct | denotes | D2 receptor |
| T9 | 372-381 | GeneOrGeneProduct | denotes | DRD2 gene |
| T10 | 414-436 | DiseaseOrPhenotypicFeature | denotes | schizophrenia patients |
| T11 | 482-490 | GeneOrGeneProduct | denotes | receptor |
| T12 | 562-566 | GeneOrGeneProduct | denotes | DRD2 |
| T13 | 576-590 | ChemicalEntity | denotes | chlorpromazine |
| T14 | 599-602 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T15 | 606-628 | DiseaseOrPhenotypicFeature | denotes | schizophrenic patients |
| T16 | 659-694 | SequenceVariant | denotes | SNP(single nucleotide polymorphism) |
| T17 | 696-708 | SequenceVariant | denotes | -141Cins>del |
| T18 | 710-715 | SequenceVariant | denotes | TaqIB |
| T19 | 717-722 | SequenceVariant | denotes | TaqID |
| T20 | 724-733 | SequenceVariant | denotes | Ser311Cys |
| T21 | 735-741 | SequenceVariant | denotes | rs6275 |
| T22 | 743-749 | SequenceVariant | denotes | rs6277 |
| T23 | 754-759 | SequenceVariant | denotes | TaqIA |
| T24 | 768-777 | GeneOrGeneProduct | denotes | DRD2 gene |
| T25 | 819-822 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T26 | 893-907 | ChemicalEntity | denotes | chlorpromazine |
| T27 | 1189-1201 | SequenceVariant | denotes | -141Cins>del |
| T28 | 1203-1208 | SequenceVariant | denotes | TaqIB |
| T29 | 1210-1216 | SequenceVariant | denotes | rs6275 |
| T30 | 1221-1226 | SequenceVariant | denotes | TaqIA |
| T31 | 1447-1456 | GeneOrGeneProduct | denotes | DRD2 gene |
| T32 | 1531-1545 | ChemicalEntity | denotes | chlorpromazine |
| T33 | 1559-1566 | OrganismTaxon | denotes | Chinese |
| T34 | 1581-1594 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
| T35 | 1672-1675 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T36 | 1679-1689 | OrganismTaxon | denotes | Caucasians |
PubTator4TogoVar
| Id | Subject | Object | Predicate | Lexical cue | resolved_to |
|---|---|---|---|---|---|
| 50 | 735-741 | SNP | denotes | rs6275 | tmVar:rs6275;VariantGroup:1;CorrespondingGene:1813;RS#:6275;CorrespondingSpecies:9606 |
| 51 | 743-749 | SNP | denotes | rs6277 | tmVar:rs6277;VariantGroup:2;CorrespondingGene:1813;RS#:6277;CorrespondingSpecies:9606 |
| 59 | 1043-1049 | SNP | denotes | rs6277 | tmVar:rs6277;VariantGroup:2;CorrespondingGene:1813;RS#:6277;CorrespondingSpecies:9606 |
| 60 | 1210-1216 | SNP | denotes | rs6275 | tmVar:rs6275;VariantGroup:1;CorrespondingGene:1813;RS#:6275;CorrespondingSpecies:9606 |
| 61 | 1281-1287 | SNP | denotes | rs6275 | tmVar:rs6275;VariantGroup:1;CorrespondingGene:1813;RS#:6275;CorrespondingSpecies:9606 |
biored-valid-gemini-r-g
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 15-19 | GeneOrGeneProduct | denotes | DRD2 |
| T2 | 38-52 | ChemicalEntity | denotes | chlorpromazine |
| T3 | 61-84 | DiseaseOrPhenotypicFeature | denotes | extrapyramidal syndrome |
| T4 | 88-95 | OrganismTaxon | denotes | Chinese |
| T5 | 96-109 | DiseaseOrPhenotypicFeature | denotes | schizophrenic |
| T6 | 125-148 | DiseaseOrPhenotypicFeature | denotes | Extrapyramidal syndrome |
| T7 | 150-153 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T8 | 247-258 | GeneOrGeneProduct | denotes | D2 receptor |
| T9 | 372-376 | GeneOrGeneProduct | denotes | DRD2 |
| T10 | 414-427 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
| T11 | 562-566 | GeneOrGeneProduct | denotes | DRD2 |
| T12 | 576-590 | ChemicalEntity | denotes | chlorpromazine |
| T13 | 599-602 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T14 | 606-619 | DiseaseOrPhenotypicFeature | denotes | schizophrenic |
| T15 | 696-708 | SequenceVariant | denotes | -141Cins>del |
| T16 | 710-715 | SequenceVariant | denotes | TaqIB |
| T17 | 717-722 | SequenceVariant | denotes | TaqID |
| T18 | 724-733 | SequenceVariant | denotes | Ser311Cys |
| T19 | 735-741 | SequenceVariant | denotes | rs6275 |
| T20 | 743-749 | SequenceVariant | denotes | rs6277 |
| T21 | 754-759 | SequenceVariant | denotes | TaqIA |
| T22 | 768-772 | GeneOrGeneProduct | denotes | DRD2 |
| T23 | 838-841 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T24 | 893-907 | ChemicalEntity | denotes | chlorpromazine |
| T25 | 1447-1451 | GeneOrGeneProduct | denotes | DRD2 |
| T26 | 1559-1566 | OrganismTaxon | denotes | Chinese |
| T27 | 1581-1594 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
| T28 | 1679-1689 | OrganismTaxon | denotes | Caucasians |
biored-valid-gpt-nr-ng
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 15-19 | GeneOrGeneProduct | denotes | DRD2 |
| T2 | 38-52 | ChemicalEntity | denotes | chlorpromazine |
| T3 | 61-84 | DiseaseOrPhenotypicFeature | denotes | extrapyramidal syndrome |
| T4 | 96-109 | DiseaseOrPhenotypicFeature | denotes | schizophrenic |
| T5 | 125-148 | DiseaseOrPhenotypicFeature | denotes | Extrapyramidal syndrome |
| T6 | 150-153 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T7 | 247-258 | GeneOrGeneProduct | denotes | D2 receptor |
| T8 | 372-381 | GeneOrGeneProduct | denotes | DRD2 gene |
| T9 | 414-427 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
| T10 | 562-566 | GeneOrGeneProduct | denotes | DRD2 |
| T11 | 576-590 | ChemicalEntity | denotes | chlorpromazine |
| T12 | 599-602 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T13 | 606-619 | DiseaseOrPhenotypicFeature | denotes | schizophrenic |
| T14 | 696-708 | SequenceVariant | denotes | -141Cins>del |
| T15 | 710-715 | SequenceVariant | denotes | TaqIB |
| T16 | 717-722 | SequenceVariant | denotes | TaqID |
| T17 | 724-733 | SequenceVariant | denotes | Ser311Cys |
| T18 | 735-741 | SequenceVariant | denotes | rs6275 |
| T19 | 743-749 | SequenceVariant | denotes | rs6277 |
| T20 | 754-759 | SequenceVariant | denotes | TaqIA |
| T21 | 768-777 | GeneOrGeneProduct | denotes | DRD2 gene |
| T22 | 785-798 | DiseaseOrPhenotypicFeature | denotes | schizophrenic |
| T23 | 819-822 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T24 | 893-907 | ChemicalEntity | denotes | chlorpromazine |
| T25 | 1022-1027 | SequenceVariant | denotes | TaqID |
| T26 | 1029-1038 | SequenceVariant | denotes | Ser311Cys |
| T27 | 1043-1049 | SequenceVariant | denotes | rs6277 |
| T28 | 1189-1201 | SequenceVariant | denotes | -141Cins>del |
| T29 | 1203-1208 | SequenceVariant | denotes | TaqIB |
| T30 | 1210-1216 | SequenceVariant | denotes | rs6275 |
| T31 | 1221-1226 | SequenceVariant | denotes | TaqIA |
| T32 | 1274-1279 | SequenceVariant | denotes | TaqIB |
| T33 | 1281-1287 | SequenceVariant | denotes | rs6275 |
| T34 | 1292-1297 | SequenceVariant | denotes | TaqIA |
| T35 | 1447-1456 | GeneOrGeneProduct | denotes | DRD2 gene |
| T36 | 1531-1545 | ChemicalEntity | denotes | chlorpromazine |
| T37 | 1581-1594 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
| T38 | 1663-1667 | GeneOrGeneProduct | denotes | DRD2 |
| T39 | 1672-1675 | DiseaseOrPhenotypicFeature | denotes | EPS |
biored-valid-gpt-nr-g
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 15-19 | GeneOrGeneProduct | denotes | DRD2 |
| T2 | 38-52 | ChemicalEntity | denotes | chlorpromazine |
| T3 | 61-84 | DiseaseOrPhenotypicFeature | denotes | extrapyramidal syndrome |
| T4 | 96-109 | DiseaseOrPhenotypicFeature | denotes | schizophrenic |
| T5 | 125-154 | DiseaseOrPhenotypicFeature | denotes | Extrapyramidal syndrome (EPS) |
| T6 | 247-258 | GeneOrGeneProduct | denotes | D2 receptor |
| T7 | 372-381 | GeneOrGeneProduct | denotes | DRD2 gene |
| T8 | 414-427 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
| T9 | 562-566 | GeneOrGeneProduct | denotes | DRD2 |
| T10 | 576-590 | ChemicalEntity | denotes | chlorpromazine |
| T11 | 599-602 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T12 | 606-619 | DiseaseOrPhenotypicFeature | denotes | schizophrenic |
| T13 | 696-708 | SequenceVariant | denotes | -141Cins>del |
| T14 | 710-715 | SequenceVariant | denotes | TaqIB |
| T15 | 717-722 | SequenceVariant | denotes | TaqID |
| T16 | 724-733 | SequenceVariant | denotes | Ser311Cys |
| T17 | 735-741 | SequenceVariant | denotes | rs6275 |
| T18 | 743-749 | SequenceVariant | denotes | rs6277 |
| T19 | 754-759 | SequenceVariant | denotes | TaqIA |
| T20 | 768-777 | GeneOrGeneProduct | denotes | DRD2 gene |
| T21 | 785-798 | DiseaseOrPhenotypicFeature | denotes | schizophrenic |
| T22 | 819-822 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T23 | 893-907 | ChemicalEntity | denotes | chlorpromazine |
| T24 | 1022-1027 | SequenceVariant | denotes | TaqID |
| T25 | 1029-1038 | SequenceVariant | denotes | Ser311Cys |
| T26 | 1043-1049 | SequenceVariant | denotes | rs6277 |
| T27 | 1189-1201 | SequenceVariant | denotes | -141Cins>del |
| T28 | 1203-1208 | SequenceVariant | denotes | TaqIB |
| T29 | 1210-1216 | SequenceVariant | denotes | rs6275 |
| T30 | 1221-1226 | SequenceVariant | denotes | TaqIA |
| T31 | 1274-1279 | SequenceVariant | denotes | TaqIB |
| T32 | 1281-1287 | SequenceVariant | denotes | rs6275 |
| T33 | 1292-1297 | SequenceVariant | denotes | TaqIA |
| T34 | 1447-1456 | GeneOrGeneProduct | denotes | DRD2 gene |
| T35 | 1531-1545 | ChemicalEntity | denotes | chlorpromazine |
| T36 | 1581-1594 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
| T37 | 1663-1667 | GeneOrGeneProduct | denotes | DRD2 |
| T38 | 1672-1675 | DiseaseOrPhenotypicFeature | denotes | EPS |
biored-valid-gpt-r-ng
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 15-19 | GeneOrGeneProduct | denotes | DRD2 |
| T2 | 38-52 | ChemicalEntity | denotes | chlorpromazine |
| T3 | 61-84 | DiseaseOrPhenotypicFeature | denotes | extrapyramidal syndrome |
| T4 | 125-148 | DiseaseOrPhenotypicFeature | denotes | Extrapyramidal syndrome |
| T5 | 150-153 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T6 | 247-258 | GeneOrGeneProduct | denotes | D2 receptor |
| T7 | 372-381 | GeneOrGeneProduct | denotes | DRD2 gene |
| T8 | 414-427 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
| T9 | 562-566 | GeneOrGeneProduct | denotes | DRD2 |
| T10 | 576-590 | ChemicalEntity | denotes | chlorpromazine |
| T11 | 599-602 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T12 | 696-708 | SequenceVariant | denotes | -141Cins>del |
| T13 | 710-715 | SequenceVariant | denotes | TaqIB |
| T14 | 717-722 | SequenceVariant | denotes | TaqID |
| T15 | 724-733 | SequenceVariant | denotes | Ser311Cys |
| T16 | 735-741 | SequenceVariant | denotes | rs6275 |
| T17 | 743-749 | SequenceVariant | denotes | rs6277 |
| T18 | 754-759 | SequenceVariant | denotes | TaqIA |
| T19 | 768-777 | GeneOrGeneProduct | denotes | DRD2 gene |
| T20 | 819-822 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T21 | 893-907 | ChemicalEntity | denotes | chlorpromazine |
| T22 | 1022-1027 | SequenceVariant | denotes | TaqID |
| T23 | 1029-1038 | SequenceVariant | denotes | Ser311Cys |
| T24 | 1043-1049 | SequenceVariant | denotes | rs6277 |
| T25 | 1189-1201 | SequenceVariant | denotes | -141Cins>del |
| T26 | 1203-1208 | SequenceVariant | denotes | TaqIB |
| T27 | 1210-1216 | SequenceVariant | denotes | rs6275 |
| T28 | 1221-1226 | SequenceVariant | denotes | TaqIA |
| T29 | 1274-1279 | SequenceVariant | denotes | TaqIB |
| T30 | 1281-1287 | SequenceVariant | denotes | rs6275 |
| T31 | 1292-1297 | SequenceVariant | denotes | TaqIA |
| T32 | 1447-1456 | GeneOrGeneProduct | denotes | DRD2 gene |
| T33 | 1531-1545 | ChemicalEntity | denotes | chlorpromazine |
| T34 | 1581-1594 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
| T35 | 1663-1667 | GeneOrGeneProduct | denotes | DRD2 |
| T36 | 1672-1675 | DiseaseOrPhenotypicFeature | denotes | EPS |
biored-valid-gpt-r-g
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 15-19 | GeneOrGeneProduct | denotes | DRD2 |
| T2 | 38-52 | ChemicalEntity | denotes | chlorpromazine |
| T3 | 61-84 | DiseaseOrPhenotypicFeature | denotes | extrapyramidal syndrome |
| T4 | 96-109 | DiseaseOrPhenotypicFeature | denotes | schizophrenic |
| T5 | 125-148 | DiseaseOrPhenotypicFeature | denotes | Extrapyramidal syndrome |
| T6 | 150-153 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T7 | 247-258 | GeneOrGeneProduct | denotes | D2 receptor |
| T8 | 372-376 | GeneOrGeneProduct | denotes | DRD2 |
| T9 | 414-427 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
| T10 | 562-566 | GeneOrGeneProduct | denotes | DRD2 |
| T11 | 576-590 | ChemicalEntity | denotes | chlorpromazine |
| T12 | 599-602 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T13 | 606-619 | DiseaseOrPhenotypicFeature | denotes | schizophrenic |
| T14 | 659-662 | SequenceVariant | denotes | SNP |
| T15 | 663-693 | SequenceVariant | denotes | single nucleotide polymorphism |
| T16 | 696-708 | SequenceVariant | denotes | -141Cins>del |
| T17 | 710-715 | SequenceVariant | denotes | TaqIB |
| T18 | 717-722 | SequenceVariant | denotes | TaqID |
| T19 | 724-733 | SequenceVariant | denotes | Ser311Cys |
| T20 | 735-741 | SequenceVariant | denotes | rs6275 |
| T21 | 743-749 | SequenceVariant | denotes | rs6277 |
| T22 | 754-759 | SequenceVariant | denotes | TaqIA |
| T23 | 768-772 | GeneOrGeneProduct | denotes | DRD2 |
| T24 | 785-798 | DiseaseOrPhenotypicFeature | denotes | schizophrenic |
| T25 | 819-822 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T26 | 893-907 | ChemicalEntity | denotes | chlorpromazine |
| T27 | 1022-1027 | SequenceVariant | denotes | TaqID |
| T28 | 1029-1038 | SequenceVariant | denotes | Ser311Cys |
| T29 | 1043-1049 | SequenceVariant | denotes | rs6277 |
| T30 | 1189-1201 | SequenceVariant | denotes | -141Cins>del |
| T31 | 1203-1208 | SequenceVariant | denotes | TaqIB |
| T32 | 1210-1216 | SequenceVariant | denotes | rs6275 |
| T33 | 1221-1226 | SequenceVariant | denotes | TaqIA |
| T34 | 1274-1279 | SequenceVariant | denotes | TaqIB |
| T35 | 1281-1287 | SequenceVariant | denotes | rs6275 |
| T36 | 1292-1297 | SequenceVariant | denotes | TaqIA |
| T37 | 1447-1451 | GeneOrGeneProduct | denotes | DRD2 |
| T38 | 1531-1545 | ChemicalEntity | denotes | chlorpromazine |
| T39 | 1581-1594 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
| T40 | 1663-1667 | GeneOrGeneProduct | denotes | DRD2 |
| T41 | 1672-1675 | DiseaseOrPhenotypicFeature | denotes | EPS |
biored-valid-gemini-nr-g
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 15-19 | GeneOrGeneProduct | denotes | DRD2 |
| T2 | 38-52 | ChemicalEntity | denotes | chlorpromazine |
| T3 | 61-84 | DiseaseOrPhenotypicFeature | denotes | extrapyramidal syndrome |
| T4 | 88-95 | OrganismTaxon | denotes | Chinese |
| T5 | 96-118 | DiseaseOrPhenotypicFeature | denotes | schizophrenic patients |
| T6 | 125-148 | DiseaseOrPhenotypicFeature | denotes | Extrapyramidal syndrome |
| T7 | 150-153 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T8 | 192-211 | ChemicalEntity | denotes | antipsychotic drugs |
| T9 | 247-258 | GeneOrGeneProduct | denotes | D2 receptor |
| T10 | 372-376 | GeneOrGeneProduct | denotes | DRD2 |
| T11 | 414-427 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
| T12 | 562-566 | GeneOrGeneProduct | denotes | DRD2 |
| T13 | 576-590 | ChemicalEntity | denotes | chlorpromazine |
| T14 | 599-602 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T15 | 606-628 | DiseaseOrPhenotypicFeature | denotes | schizophrenic patients |
| T16 | 696-708 | SequenceVariant | denotes | -141Cins>del |
| T17 | 710-715 | SequenceVariant | denotes | TaqIB |
| T18 | 717-722 | SequenceVariant | denotes | TaqID |
| T19 | 724-733 | SequenceVariant | denotes | Ser311Cys |
| T20 | 735-741 | SequenceVariant | denotes | rs6275 |
| T21 | 743-749 | SequenceVariant | denotes | rs6277 |
| T22 | 754-759 | SequenceVariant | denotes | TaqIA |
| T23 | 768-772 | GeneOrGeneProduct | denotes | DRD2 |
| T24 | 785-798 | DiseaseOrPhenotypicFeature | denotes | schizophrenic |
| T25 | 819-822 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T26 | 893-907 | ChemicalEntity | denotes | chlorpromazine |
| T27 | 1022-1027 | SequenceVariant | denotes | TaqID |
| T28 | 1029-1038 | SequenceVariant | denotes | Ser311Cys |
| T29 | 1043-1049 | SequenceVariant | denotes | rs6277 |
| T30 | 1189-1201 | SequenceVariant | denotes | -141Cins>del |
| T31 | 1203-1208 | SequenceVariant | denotes | TaqIB |
| T32 | 1210-1216 | SequenceVariant | denotes | rs6275 |
| T33 | 1221-1226 | SequenceVariant | denotes | TaqIA |
| T34 | 1447-1451 | GeneOrGeneProduct | denotes | DRD2 |
| T35 | 1531-1545 | ChemicalEntity | denotes | chlorpromazine |
| T36 | 1559-1566 | OrganismTaxon | denotes | Chinese |
| T37 | 1581-1594 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
| T38 | 1672-1675 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T39 | 1679-1689 | OrganismTaxon | denotes | Caucasians |
biored-valid-gpt-r-m
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 15-19 | GeneOrGeneProduct | denotes | DRD2 |
| T2 | 38-52 | ChemicalEntity | denotes | chlorpromazine |
| T3 | 61-84 | DiseaseOrPhenotypicFeature | denotes | extrapyramidal syndrome |
| T4 | 96-109 | DiseaseOrPhenotypicFeature | denotes | schizophrenic |
| T5 | 110-118 | OrganismTaxon | denotes | patients |
| T6 | 125-148 | DiseaseOrPhenotypicFeature | denotes | Extrapyramidal syndrome |
| T7 | 150-153 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T8 | 247-258 | GeneOrGeneProduct | denotes | D2 receptor |
| T9 | 372-376 | GeneOrGeneProduct | denotes | DRD2 |
| T10 | 414-427 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
| T11 | 428-436 | OrganismTaxon | denotes | patients |
| T12 | 562-566 | GeneOrGeneProduct | denotes | DRD2 |
| T13 | 576-590 | ChemicalEntity | denotes | chlorpromazine |
| T14 | 599-602 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T15 | 606-619 | DiseaseOrPhenotypicFeature | denotes | schizophrenic |
| T16 | 620-628 | OrganismTaxon | denotes | patients |
| T17 | 696-708 | SequenceVariant | denotes | -141Cins>del |
| T18 | 710-715 | SequenceVariant | denotes | TaqIB |
| T19 | 717-722 | SequenceVariant | denotes | TaqID |
| T20 | 724-733 | SequenceVariant | denotes | Ser311Cys |
| T21 | 735-741 | SequenceVariant | denotes | rs6275 |
| T22 | 743-749 | SequenceVariant | denotes | rs6277 |
| T23 | 754-759 | SequenceVariant | denotes | TaqIA |
| T24 | 768-772 | GeneOrGeneProduct | denotes | DRD2 |
| T25 | 785-798 | DiseaseOrPhenotypicFeature | denotes | schizophrenic |
| T26 | 799-809 | OrganismTaxon | denotes | inpatients |
| T27 | 819-822 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T28 | 893-907 | ChemicalEntity | denotes | chlorpromazine |
| T29 | 1022-1027 | SequenceVariant | denotes | TaqID |
| T30 | 1029-1038 | SequenceVariant | denotes | Ser311Cys |
| T31 | 1043-1049 | SequenceVariant | denotes | rs6277 |
| T32 | 1189-1201 | SequenceVariant | denotes | -141Cins>del |
| T33 | 1203-1208 | SequenceVariant | denotes | TaqIB |
| T34 | 1210-1216 | SequenceVariant | denotes | rs6275 |
| T35 | 1221-1226 | SequenceVariant | denotes | TaqIA |
| T36 | 1274-1279 | SequenceVariant | denotes | TaqIB |
| T37 | 1281-1287 | SequenceVariant | denotes | rs6275 |
| T38 | 1292-1297 | SequenceVariant | denotes | TaqIA |
| T39 | 1447-1451 | GeneOrGeneProduct | denotes | DRD2 |
| T40 | 1531-1545 | ChemicalEntity | denotes | chlorpromazine |
| T41 | 1567-1575 | OrganismTaxon | denotes | patients |
| T42 | 1581-1594 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
| T43 | 1663-1667 | GeneOrGeneProduct | denotes | DRD2 |
| T44 | 1672-1675 | DiseaseOrPhenotypicFeature | denotes | EPS |
biored-valid-gemini-r-m
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 15-19 | GeneOrGeneProduct | denotes | DRD2 |
| T2 | 38-52 | ChemicalEntity | denotes | chlorpromazine |
| T3 | 61-84 | DiseaseOrPhenotypicFeature | denotes | extrapyramidal syndrome |
| T4 | 88-95 | OrganismTaxon | denotes | Chinese |
| T5 | 96-109 | DiseaseOrPhenotypicFeature | denotes | schizophrenic |
| T6 | 110-118 | OrganismTaxon | denotes | patients |
| T7 | 125-154 | DiseaseOrPhenotypicFeature | denotes | Extrapyramidal syndrome (EPS) |
| T8 | 192-211 | ChemicalEntity | denotes | antipsychotic drugs |
| T9 | 247-258 | GeneOrGeneProduct | denotes | D2 receptor |
| T10 | 372-376 | GeneOrGeneProduct | denotes | DRD2 |
| T11 | 414-427 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
| T12 | 428-436 | OrganismTaxon | denotes | patients |
| T13 | 562-566 | GeneOrGeneProduct | denotes | DRD2 |
| T14 | 576-590 | ChemicalEntity | denotes | chlorpromazine |
| T15 | 599-602 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T16 | 606-619 | DiseaseOrPhenotypicFeature | denotes | schizophrenic |
| T17 | 696-708 | SequenceVariant | denotes | -141Cins>del |
| T18 | 710-715 | SequenceVariant | denotes | TaqIB |
| T19 | 717-722 | SequenceVariant | denotes | TaqID |
| T20 | 724-733 | SequenceVariant | denotes | Ser311Cys |
| T21 | 735-741 | SequenceVariant | denotes | rs6275 |
| T22 | 743-749 | SequenceVariant | denotes | rs6277 |
| T23 | 754-759 | SequenceVariant | denotes | TaqIA |
| T24 | 768-772 | GeneOrGeneProduct | denotes | DRD2 |
| T25 | 799-809 | OrganismTaxon | denotes | inpatients |
| T26 | 819-822 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T27 | 838-841 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T28 | 893-907 | ChemicalEntity | denotes | chlorpromazine |
| T29 | 1203-1208 | SequenceVariant | denotes | TaqIB |
| T30 | 1210-1216 | SequenceVariant | denotes | rs6275 |
| T31 | 1221-1226 | SequenceVariant | denotes | TaqIA |
| T32 | 1447-1451 | GeneOrGeneProduct | denotes | DRD2 |
| T33 | 1559-1566 | OrganismTaxon | denotes | Chinese |
| T34 | 1581-1594 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
| T35 | 1679-1689 | OrganismTaxon | denotes | Caucasians |
biored-valid-deepseek-r-m
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 15-19 | GeneOrGeneProduct | denotes | DRD2 |
| T2 | 38-52 | ChemicalEntity | denotes | chlorpromazine |
| T3 | 61-84 | DiseaseOrPhenotypicFeature | denotes | extrapyramidal syndrome |
| T4 | 96-109 | DiseaseOrPhenotypicFeature | denotes | schizophrenic |
| T5 | 150-153 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T6 | 247-258 | GeneOrGeneProduct | denotes | D2 receptor |
| T7 | 372-376 | GeneOrGeneProduct | denotes | DRD2 |
| T8 | 562-566 | GeneOrGeneProduct | denotes | DRD2 |
| T9 | 576-590 | ChemicalEntity | denotes | chlorpromazine |
| T10 | 599-602 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T11 | 606-619 | DiseaseOrPhenotypicFeature | denotes | schizophrenic |
| T12 | 659-662 | SequenceVariant | denotes | SNP |
| T13 | 696-708 | SequenceVariant | denotes | -141Cins>del |
| T14 | 710-715 | SequenceVariant | denotes | TaqIB |
| T15 | 717-722 | SequenceVariant | denotes | TaqID |
| T16 | 724-733 | SequenceVariant | denotes | Ser311Cys |
| T17 | 735-741 | SequenceVariant | denotes | rs6275 |
| T18 | 743-749 | SequenceVariant | denotes | rs6277 |
| T19 | 754-759 | SequenceVariant | denotes | TaqIA |
| T20 | 768-772 | GeneOrGeneProduct | denotes | DRD2 |
| T21 | 838-841 | DiseaseOrPhenotypicFeature | denotes | EPS |
| T22 | 893-907 | ChemicalEntity | denotes | chlorpromazine |
| T23 | 1447-1451 | GeneOrGeneProduct | denotes | DRD2 |
| T24 | 1581-1594 | DiseaseOrPhenotypicFeature | denotes | schizophrenia |
PubTatorOnTogoVar
| Id | Subject | Object | Predicate | Lexical cue | resolved_to |
|---|---|---|---|---|---|
| 50 | 735-741 | SNP | denotes | rs6275 | tmVar:rs6275;VariantGroup:1;CorrespondingGene:1813;RS#:6275;CorrespondingSpecies:9606 |
| 51 | 743-749 | SNP | denotes | rs6277 | tmVar:rs6277;VariantGroup:2;CorrespondingGene:1813;RS#:6277;CorrespondingSpecies:9606 |
| 59 | 1043-1049 | SNP | denotes | rs6277 | tmVar:rs6277;VariantGroup:2;CorrespondingGene:1813;RS#:6277;CorrespondingSpecies:9606 |
| 60 | 1210-1216 | SNP | denotes | rs6275 | tmVar:rs6275;VariantGroup:1;CorrespondingGene:1813;RS#:6275;CorrespondingSpecies:9606 |
| 61 | 1281-1287 | SNP | denotes | rs6275 | tmVar:rs6275;VariantGroup:1;CorrespondingGene:1813;RS#:6275;CorrespondingSpecies:9606 |
| T1 | 735-741 | SNP | denotes | rs6275 | tmVar:rs6275;VariantGroup:1;CorrespondingGene:1813;RS#:6275;CorrespondingSpecies:9606 |
| T2 | 743-749 | SNP | denotes | rs6277 | tmVar:rs6277;VariantGroup:2;CorrespondingGene:1813;RS#:6277;CorrespondingSpecies:9606 |
| T3 | 1043-1049 | SNP | denotes | rs6277 | tmVar:rs6277;VariantGroup:2;CorrespondingGene:1813;RS#:6277;CorrespondingSpecies:9606 |
| T4 | 1210-1216 | SNP | denotes | rs6275 | tmVar:rs6275;VariantGroup:1;CorrespondingGene:1813;RS#:6275;CorrespondingSpecies:9606 |
| T5 | 1281-1287 | SNP | denotes | rs6275 | tmVar:rs6275;VariantGroup:1;CorrespondingGene:1813;RS#:6275;CorrespondingSpecies:9606 |